Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Esophageal Neoplasms 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Duodenal Neoplasms 2Diarrhea 2Colorectal Neoplasms 2Carcinoid Tumor 2Adenoma, Islet Cell 2Acromegaly 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vomiting 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Serotonin Syndrome 1Sarcoma 1Rectal Neoplasms 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Octreotide × Clear all
NCT00257426 2012-02-14

Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
31 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡